# BMAL2

## Overview
BMAL2, or brain and muscle ARNT-like protein 2, is a gene that encodes a transcription factor belonging to the basic helix-loop-helix (bHLH) PER-ARNT-SIM (PAS) family. The protein product, basic helix-loop-helix ARNT like 2, plays a pivotal role in the regulation of circadian rhythms by forming heterodimers with other transcription factors such as CLOCK and NPAS2. These heterodimers bind to E-box elements in DNA, thereby activating the transcription of clock-controlled genes essential for maintaining the circadian feedback loop (Sasaki2009Preferential; Schoenhard2002Alternative). BMAL2 is characterized by its structural domains, including a bHLH domain for DNA binding and dimerization, and PAS domains for protein-protein interactions, which contribute to its functional versatility (Kolonko2019bHLH–PAS; Wu2017Structural). The gene undergoes alternative splicing, resulting in multiple isoforms that exhibit distinct transcriptional activities, allowing for tissue-specific regulation of circadian rhythms (Schoenhard2002Alternative). BMAL2's interactions with other proteins, such as PER2, modulate its activity, highlighting its unique regulatory role in circadian transcription (Sasaki2009Preferential). Additionally, BMAL2 is implicated in various physiological and pathological processes, including hypoxic metabolism and oncogenic pathways, underscoring its clinical significance (Maurer2023Rasdependent).

## Structure
The BMAL2 protein, encoded by the human BMAL2 gene, is a member of the basic helix-loop-helix (bHLH) PER-ARNT-SIM (PAS) family of transcription factors. It contains a bHLH domain for DNA binding and dimerization, and two PAS domains (PAS-A and PAS-B) for protein-protein interactions (Wu2017Structural). The bHLH domain typically comprises two long α helices connected by a short loop, which interacts with the DNA's major groove (Kolonko2019bHLH–PAS).

BMAL2 undergoes alternative splicing, resulting in multiple splice variants with distinct functional properties. These variants differ primarily in their NH2-terminal regions, composed of exons 1-5, followed by 13 invariant exons encoding the bHLH, PAS-A, PAS-B, and COOH-terminal domains (Schoenhard2002Alternative). The splice variants exhibit varying transcriptional activation capacities when interacting with mCLOCK, influencing circadian rhythms (Schoenhard2002Alternative).

The protein's structure is characterized by intrinsically disordered regions, particularly in the C-terminal regions, which are involved in protein regulation and allow for post-translational modifications (Kolonko2019bHLH–PAS). These structural features contribute to the functional flexibility of BMAL2 in cellular signaling.

## Function
BMAL2 (basic helix-loop-helix ARNT like 2) is a transcription factor that plays a significant role in the regulation of circadian rhythms. It forms heterodimers with CLOCK or NPAS2, which bind to E-box elements in DNA to activate the transcription of clock-controlled genes. This process is crucial for maintaining the circadian feedback loop, which regulates various physiological functions, including sleep-wake cycles and metabolism (Sasaki2009Preferential; Schoenhard2002Alternative).

BMAL2 is involved in the positive regulation of an autoregulatory feedback loop essential for circadian rhythms. It is expressed in the suprachiasmatic nucleus, the central circadian oscillator in mammals, and can transactivate E-box-mediated transcription, although with less efficiency compared to BMAL1 (Okano2001Cloning). BMAL2's activity is modulated by interactions with other proteins, such as PER2, which preferentially inhibits BMAL2-CLOCK activity, highlighting a distinct regulatory role in circadian transcription (Sasaki2009Preferential).

Alternative splicing of BMAL2 generates isoforms with varying transcriptional activities, allowing for tissue-specific regulation of circadian rhythms. This splicing may influence the amplitudes of both central and peripheral circadian oscillators, providing a mechanism to accommodate different metabolic demands and physiological roles (Schoenhard2002Alternative).

## Clinical Significance
BMAL2 has been implicated in several diseases and conditions due to its role in regulating hypoxic metabolism and its interaction with oncogenic pathways. In pancreatic ductal adenocarcinoma (PDAC), BMAL2 acts as a master transcriptional regulator, significantly influencing tumor initiation, progression, and patient prognosis. Its activity is associated with poor outcomes, particularly in high-grade tumors, and is linked to KRAS signaling pathways, suggesting that BMAL2 operates downstream of mutant KRAS to facilitate phenotypic transitions in pancreatic cancer (Maurer2023Rasdependent). BMAL2 stabilizes HIF1A under hypoxic conditions, which is crucial for the hypoxia response in PDAC cells, and its knockout leads to reduced levels of HIF1A and LDHA, indicating a blunted hypoxic response (Maurer2023Rasdependent).

In the context of metabolic disorders, a study found that the BMAL2 rs7958822 single nucleotide polymorphism (SNP) is associated with an increased risk of type 2 diabetes mellitus (T2DM) in obese Japanese individuals. The A/G and A/A genotypes of this SNP were linked to higher odds of T2DM compared to the G/G genotype, highlighting a potential gene-environment interaction between BMAL2 genotypes and obesity (Yamaguchi2015Association).

## Interactions
BMAL2 interacts with several proteins and nucleic acids, playing a significant role in circadian rhythm regulation. It forms heterodimers with CLOCK to activate E-box-dependent transcription, similar to its paralog BMAL1. However, BMAL2 exhibits a stronger interaction with the negative regulator PER2 compared to BMAL1, as demonstrated by co-immunoprecipitation experiments. This interaction suggests a functional partnership where PER2 shows a stronger inhibitory effect on BMAL2-CLOCK activity than on BMAL1-CLOCK (Sasaki2009Preferential).

BMAL2 is less sensitive to CRY-mediated repression but more sensitive to PER2-mediated repression than BMAL1. This distinct sensitivity affects its role in circadian transcription (Sasaki2009Preferential). BMAL2 also interacts with HIF1A, influencing hypoxic metabolism in pancreatic cancer. This interaction is crucial for HIF1A stabilization under hypoxic conditions, indicating a regulatory relationship between BMAL2 and hypoxia response pathways (Maurer2023Rasdependent).

BMAL2 can substitute for BMAL1 in certain contexts, forming heterodimers with NPAS2 to regulate circadian gene expression. This functional redundancy highlights its ability to interact with various transcription factors to maintain circadian rhythms (Shi2010Circadian).


## References


[1. (Sasaki2009Preferential) Momoko Sasaki, Hikari Yoshitane, Ngoc-Hien Du, Toshiyuki Okano, and Yoshitaka Fukada. Preferential inhibition of bmal2-clock activity by per2 reemphasizes its negative role and a positive role of bmal2 in the circadian transcription. Journal of Biological Chemistry, 284(37):25149–25159, September 2009. URL: http://dx.doi.org/10.1074/jbc.M109.040758, doi:10.1074/jbc.m109.040758. This article has 76 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M109.040758)

[2. (Schoenhard2002Alternative) John A. Schoenhard, Mesut Eren, Carl H. Johnson, and Douglas E. Vaughan. Alternative splicing yields novel bmal2 variants: tissue distribution and functional characterization. American Journal of Physiology-Cell Physiology, 283(1):C103–C114, July 2002. URL: http://dx.doi.org/10.1152/ajpcell.00541.2001, doi:10.1152/ajpcell.00541.2001. This article has 41 citations.](https://doi.org/10.1152/ajpcell.00541.2001)

[3. (Okano2001Cloning) Toshiyuki Okano, Momoko Sasaki, and Yoshitaka Fukada. Cloning of mouse bmal2 and its daily expression profile in the suprachiasmatic nucleus: a remarkable acceleration of bmal2 sequence divergence after bmal gene duplication. Neuroscience Letters, 300(2):111–114, March 2001. URL: http://dx.doi.org/10.1016/s0304-3940(01)01581-6, doi:10.1016/s0304-3940(01)01581-6. This article has 36 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0304-3940(01)01581-6)

[4. (Wu2017Structural) Dalei Wu and Fraydoon Rastinejad. Structural characterization of mammalian bhlh-pas transcription factors. Current Opinion in Structural Biology, 43:1–9, April 2017. URL: http://dx.doi.org/10.1016/j.sbi.2016.09.011, doi:10.1016/j.sbi.2016.09.011. This article has 84 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.sbi.2016.09.011)

[5. (Yamaguchi2015Association) Miwa Yamaguchi, Hirokazu Uemura, Kokichi Arisawa, Sakurako Katsuura-Kamano, Nobuyuki Hamajima, Asahi Hishida, Shino Suma, Isao Oze, Kazuyo Nakamura, Naoyuki Takashima, Sadao Suzuki, Rie Ibusuki, Haruo Mikami, Keizo Ohnaka, Nagato Kuriyama, Michiaki Kubo, and Hideo Tanaka. Association between brain-muscle-arnt-like protein-2 (bmal2) gene polymorphism and type 2 diabetes mellitus in obese japanese individuals: a cross-sectional analysis of the japan multi-institutional collaborative cohort study. Diabetes Research and Clinical Practice, 110(3):301–308, December 2015. URL: http://dx.doi.org/10.1016/j.diabres.2015.10.009, doi:10.1016/j.diabres.2015.10.009. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.diabres.2015.10.009)

6. (Maurer2023Rasdependent) Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancer. This article has 2 citations.

[7. (Shi2010Circadian) Shuqun Shi, Akiko Hida, Owen P. McGuinness, David H. Wasserman, Shin Yamazaki, and Carl Hirschie Johnson. Circadian clock gene bmal1 is not essential; functional replacement with its paralog, bmal2. Current Biology, 20(4):316–321, February 2010. URL: http://dx.doi.org/10.1016/j.cub.2009.12.034, doi:10.1016/j.cub.2009.12.034. This article has 109 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cub.2009.12.034)

[8. (Kolonko2019bHLH–PAS) Marta Kolonko and Beata Greb-Markiewicz. Bhlh–pas proteins: their structure and intrinsic disorder. International Journal of Molecular Sciences, 20(15):3653, July 2019. URL: http://dx.doi.org/10.3390/ijms20153653, doi:10.3390/ijms20153653. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20153653)